Loading...
A meta-analysis of safety and efficacy of regorafenib for refractory metastatic colorectal cancer
BACKGROUND: Patients with metastatic colorectal cancer (mCRC) often suffer from progressive disease despite previous therapy. It has been a great challenge for those patients. In 2012, regorafenib was approved for mCRC. In this meta-analysis, we aimed to collect and present existing data to exploret...
Saved in:
| Published in: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Wolters Kluwer Health
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6200445/ https://ncbi.nlm.nih.gov/pubmed/30290640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000012635 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|